ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer-Reference-Cited by-同舟云学术

ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer

Published:2008-01 Issue:1 Volume:44 Page:54-60
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kim Min Kyoung,Cho Kyung-Ja,Kwon Gui Young,Park Seung-Il,Kim Yong Hee,Kim Jong Hoon,Song Ho-Young,Shin Ji Hoon,Jung Hwoon Yong,Lee Gin Hyug,Choi Kee Don,Kim Sung-Bae

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma;Urba;J Clin Oncol,2001

3. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma;Walsh;N Engl J Med,1996

4. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma;Lee;Ann Oncol,2004

5. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial;Burmeister;Lancet Oncol,2005

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells;Journal of Drug Delivery Science and Technology;2023-09

2. XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer;Cells;2023-05-25

3. Advances in targeting of miR‑10‑associated lncRNAs/circRNAs for the management of cancer (Review);Oncology Letters;2023-01-19

4. XPF-ERCC1 blocker improves the therapeutic efficacy of 5-FU- and oxaliplatin-based chemoradiotherapy in rectal cancer;2022-12-05

5. Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis;Oncology Research and Treatment;2020